Search Results 61-70 of 16495 for ������������KA���:ZA31���24������ ���������������������������������
Rochester, Minn. The purpose of this study is to evaluate how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the ...
Patients completed bowel function questionnaires weekly during therapy, afterward for six weeks and at 12 and 24 months after therapy. Health care providers ...
Mayo Clinic researchers capture first signs of ovarian cancer risk. By. Alison Satake. June 24, 2025. Share this: Share to facebook · Share to twitter · Share ...
National Institute of Neurological Disorders and Stroke NINDS.
... KA, Sehgal AR, Goy A, Hill BT, Andreadis C, Munoz ... 2024 Sep 24; 8 (18):4877-4885. View PubMed; Zinzani ... 2022 Dec; 24 (12):1863-1872 Epub 2022 Nov 07
creatinine clearance (CrCl) ≥ 30 mL/min., as measured by a 24-hour urine collection, or estimated by the Cockcroft and Gault formula; or; serum creatinine ...
We also wish to evaluate the feasibility, barriers to completion, and sustainability of this intervention at the 24, and 52-week marks. Lastly, we aim to ...
2024 Jul 24; 13 (7):546-558. View PubMed ... 2023 Jan 24; 81 (3):207-219 Epub 2022 Oct 31. View ... Alpert JS, Jaffe AS, White HD, Thygesen KA. Type ...
Telephone consultations and referrals may be arranged by contacting the Referring Physician Service. The office is available 24 hours a day, seven days a week.
Rochester, Minnesota: 24-003478. Sponsor Protocol Number: 24-003478. About this study. The purpose of this studyis to evaluate differences in the amount of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.